Evidence map›Paper›PMID 34912821›Full record

ArticleFrontiers in medicine2021

Case Report: A Rare Case of Lupus Nephritis Associated With Mantle Cell Lymphoma.

Daorina Bao, Ying Tan, Xiaojuan Yu, Bingjie Wang, Hui Wang, Rong Xu, Fude Zhou, Minghui Zhao

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daorina BaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Ying TanRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Xiaojuan YuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Bingjie WangDepartment of Hematology, Peking University First Hospital, Beijing, China.
Hui WangLaboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, China.
Rong XuRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Fude ZhouRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Minghui ZhaoRenal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNMinistry of Education of the People's Republic of China · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, we described a very rare case of secondary lupus nephritis associated with B-cell lymphoma. An 84-year-old man was hospitalized at our institute for lower extremity edema persisting for over 2 months. He was diagnosed with systemic lupus erythematosus based on clinical and laboratory criteria, which showed impaired renal function and nephrotic syndrome with predominant hematuria. Renal biopsy showed IV+V lupus nephritis with highly infiltrated lymphoid cells in the kidney. Secondary lupus nephritis was suspected based on the possible pathogenesis of glomerular injury due to mantle cell lymphoma. Low-dose dexamethasone, rituximab, and lenalidomide were immediately started on the patient, and his renal function was improved after the first cycle of chemotherapy.

Indexed as

acute kidney injurylupus nephritismantle cell lymphomanon-Hodgkin lymphomasecondary SLE

Identifiers

PMID34912821
PMCPMC8666564
OpenAlexW3215101191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.